
    
      A multicenter, randomized controlled study with a blinded control arm. Open label arm is
      observational for lung nodule management. The clinical trial will evaluate the clinical
      utility of the Nodify XL2 integrated classifier when used in the clinical management of new,
      incidentally identified solid lung nodules assessed as < 50% risk of cancer by Mayo risk
      prediction algorithm.
    
  